Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic analysis in the treatment of Hodgkin lymphoma.

Leukemia & lymphoma - 1 Aug 2013

Altés Albert, Paré Laia, Esquirol Albert, Xicoy Blanca, Rámila Elena, Vicente Laura, López Rosario, Orriols Jaume, Vall-llovera Ferran, Sánchez-González Blanca, del Río Elisabeth, Sureda Anna, Páez David, Baiget Montserrat

Abstract excerpt

About 15-20% of patients with Hodgkin lymphoma (HL) treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy ± radiotherapy still die following relapse or progressive disease. The outcome might be influenced by gene polymorphisms influencing chemotherapy metabolism. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Glutathione Transferase

Share to Hodgkin Disease

Share to Neoplasm Staging

Share to Pharmacogenetics

Share to Radiotherapy

Source

Identifiers

PMID: 23323945
DOI: 10.3109/10428194.2012.752080

Genes

GSTM1
BLMH
GSTP1
GSTT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23323945-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic analysis in the treatment of Hodgkin lymphoma.PMID 23323945Read ↗

Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosisSemantic proximity Read ↗

Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.Semantic proximity Read ↗

Polymorphisms of glutathione S-transferase mu 1, theta 1, and pi 1 genes and prognosis in Hodgkin lymphoma.Semantic proximity Read ↗

Polymorphisms of glutathione S-transferase Mu 1, glutathione S-transferase theta 1 and glutathione S-transferase Pi 1 genes in Hodgkin's lymphoma susceptibility and progression.Semantic proximity Read ↗

Pharmacogenetic considerations for non-Hodgkin's lymphoma therapy.Semantic proximity Read ↗

Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.Semantic proximity Read ↗

Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma.Semantic proximity Read ↗

Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma.Semantic proximity Read ↗

The Impact of Drug Metabolism Gene Polymorphisms on Therapeutic Response and Survival in Diffuse Large B-Cell Lymphoma Patients.Semantic proximity Read ↗

Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.Semantic proximity Read ↗

Association between glutathione S-transferase genotypes and Hodgkin's lymphoma risk and prognosis.Semantic proximity Read ↗

Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.